2 days AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell? Zacks
AZN’s key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales. It has several candidates with blockbuster potential.
Biotech · China · Politics · U.S.
X